Icure Pharmaceutical Incorporation Free Cash Flow Generation Index

Latest as of June 2020: 39.07x

Icure Pharmaceutical Incorporation free cash flow generation index. Icure Pharmaceutical Incorporation (175250) has a Free Cash Flow Generation Index of 39.07x as of June 2020. Free cash flow of ₩7.64 Billion represents 39% of operating cash flow (₩195.44 Million).

FCF Generation Index

39.07x
Free Cash Flow / Operating CF

Free Cash Flow

₩7.64 Billion
KRW

Operating Cash Flow

₩195.44 Million
KRW

Capital Expenditures

₩7.44 Billion
KRW

Free Cash Flow Generation Index of Icure Pharmaceutical Incorporation (2017–2017)

Free cash flow generation index of Icure Pharmaceutical Incorporation from 2017 to 2017. Historical FCF Generation Index trend for Icure Pharmaceutical Incorporation across 1 annual periods. See 175250 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Icure Pharmaceutical Incorporation Free Cash Flow Generation Index by Year (2017–2017)

Icure Pharmaceutical Incorporation free cash flow generation index by year from 2017 to 2017. Year-by-year Free Cash Flow Generation Index for Icure Pharmaceutical Incorporation. For the full cash flow conversion analysis, see Icure Pharmaceutical Incorporation (175250) cash flow conversion.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2017 10.02x ₩11.22 Billion ₩1.12 Billion ₩10.10 Billion —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).